FDA Cancels Cipla Pharma License Following Promotional Violations

U.S. regulators have revoked the operating license of Cipla’s Pune manufacturing facility and ordered a market recall after seizing unauthorized promotional materials and stock worth over ₹11 lakh.

28 Aug, 13:45 — 28 Aug, 13:45

Post Share

Sources

Showing 1 of 1 sources

hindustan-timesMostly Factual1d ago

FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'

The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.

Read full article →

PERSPECTA

PERSPECTA

FDA Cancels Cipla Pharma License Following Promotional Violations

Sources

FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'

Related Stories

Rabies Detected in Goats at North Carolina Mobile Petting Zoo

48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room

Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy

Study Reveals Hidden Arterial Calcification in Young Adults

PERSPECTA